Table 5.
Bleeding following SBRT for prostate cancer: hematuria (patient-reported responses to Question 4c of the EPIC-26) and hematochezia (patient-reported responses to Question 6d of the EPIC-26).
| Initial Consult | Start | 1 mon | 3 mon | 6 mon | 9 mon | 12 mon | 18 mon | 24 mon | 30 mon | 36 mon | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hematuria | |||||||||||
| No problem | 96.3% | 93.2% | 100.0% | 97.7% | 100.0% | 95.3% | 97.7% | 97.7% | 95.3% | 97.5% | 97.7% |
| Very Small- Small problem | 3.7% | 6.8% | 0.0% | 2.3% | 0.0% | 2.3% | 0.0% | 0.0% | 2.3% | 2.5% | 2.3% |
| Moderate - Big problem | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.3% | 2.3% | 2.3% | 2.3% | 0.0% | 0.0% |
| Hematochezia | |||||||||||
| No problem | 92.6% | 95.5% | 83.7% | 95.3% | 88.4% | 93.0% | 95.3% | 90.9% | 88.4% | 90.0% | 90.7% |
| Very small- Small problem | 7.4% | 4.5% | 14.0% | 4.7% | 7.0% | 4.7% | 4.7% | 6.8% | 11.6% | 7.5% | 9.3% |
| Moderate - Big problem | 0.0% | 0.0% | 2.3% | 0.0% | 4.7% | 2.3% | 0.0% | 2.3% | 0.0% | 2.5% | 0.0% |